JPS6452716A - Endermically applicable preparation containing eperisone, tolperisone or salt thereof - Google Patents
Endermically applicable preparation containing eperisone, tolperisone or salt thereofInfo
- Publication number
- JPS6452716A JPS6452716A JP63062944A JP6294488A JPS6452716A JP S6452716 A JPS6452716 A JP S6452716A JP 63062944 A JP63062944 A JP 63062944A JP 6294488 A JP6294488 A JP 6294488A JP S6452716 A JPS6452716 A JP S6452716A
- Authority
- JP
- Japan
- Prior art keywords
- tolperisone
- salt
- endermically
- preparation containing
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63062944A JPH0720866B2 (ja) | 1987-05-15 | 1988-03-16 | エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤 |
FI881978A FI91361C (fi) | 1987-05-15 | 1988-04-27 | Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi |
AT88107085T ATE56144T1 (de) | 1987-05-15 | 1988-05-03 | Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt. |
DE8888107085T DE3860550D1 (de) | 1987-05-15 | 1988-05-03 | Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt. |
EP88107085A EP0295411B1 (en) | 1987-05-15 | 1988-05-03 | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof |
DK253988D DK169016B1 (da) | 1987-05-15 | 1988-05-09 | Farmaceutisk præparat med indhold af eperison eller tolperison, eller et salt deraf, til indgivelse gennem huden |
DK253988A DK253988A (da) | 1987-05-15 | 1988-05-09 | Farmaceutisk praeparat med indhold af eperison eller tolperison, eller et salt deraf, til indgivelse gennem huden |
US07/193,713 US5059427A (en) | 1987-05-15 | 1988-05-13 | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
NO882103A NO175515C (no) | 1987-05-15 | 1988-05-13 | Fremgangsmåte for fremstilling av et farmasöytisk preparat for perkutan tilförsel |
CA000566696A CA1310270C (en) | 1987-05-15 | 1988-05-13 | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
US07/561,707 US5073375A (en) | 1987-05-15 | 1990-08-02 | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11866087 | 1987-05-15 | ||
JP62-118660 | 1987-05-15 | ||
JP63062944A JPH0720866B2 (ja) | 1987-05-15 | 1988-03-16 | エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6452716A true JPS6452716A (en) | 1989-02-28 |
JPH0720866B2 JPH0720866B2 (ja) | 1995-03-08 |
Family
ID=26404007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63062944A Expired - Fee Related JPH0720866B2 (ja) | 1987-05-15 | 1988-03-16 | エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤 |
Country Status (8)
Country | Link |
---|---|
US (2) | US5059427A (ja) |
EP (1) | EP0295411B1 (ja) |
JP (1) | JPH0720866B2 (ja) |
CA (1) | CA1310270C (ja) |
DE (1) | DE3860550D1 (ja) |
DK (2) | DK169016B1 (ja) |
FI (1) | FI91361C (ja) |
NO (1) | NO175515C (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06247846A (ja) * | 1993-02-22 | 1994-09-06 | Toko Yakuhin Kogyo Kk | 塩酸リトドリンの経皮吸収製剤用組成物 |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
US5252334A (en) * | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
US5252588A (en) * | 1990-04-27 | 1993-10-12 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation |
MY115126A (en) * | 1990-04-27 | 2003-04-30 | Seikisui Chemical Co Ltd | Percutaneously absorbable eperisone or tolperisone preparation. |
AU653156B2 (en) * | 1990-06-14 | 1994-09-22 | Dermamed | Transdermal administration to humans and animals |
US5900250A (en) | 1992-05-13 | 1999-05-04 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutnin |
JP3190441B2 (ja) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | 塩酸アゼラスチンを含有する安定な製剤 |
JPH08512054A (ja) * | 1993-06-25 | 1996-12-17 | アルザ・コーポレーション | 経皮系におけるポリ−n−ビニルアミドの含有 |
US5407678A (en) * | 1993-09-01 | 1995-04-18 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Petroleum jelly cream |
NZ275615A (en) * | 1993-09-29 | 1996-11-26 | Alza Corp | Oxybutynin composition containing monoglyceride and lactate ester as permeability enhancers; device for transdermal administration of oxybutynin |
US5420106A (en) * | 1994-03-22 | 1995-05-30 | Bristol-Myers Squibb Company | Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
US5733900A (en) * | 1994-04-21 | 1998-03-31 | Hisamitsu Pharmaceutical Co., Inc. | Percutaneous administration base composition and percutaneous administration medicinal composition comprising said base composition and medicine |
GB9500983D0 (en) * | 1995-01-19 | 1995-03-08 | Agrevo Uk Ltd | Pesticidal compositions |
IL122432A (en) * | 1995-06-07 | 2000-07-16 | Cygnus Therapeutic Systems | Transdermal patch for preventing ovulation |
KR100858856B1 (ko) † | 1999-02-08 | 2008-09-17 | 인타르시아 세라퓨틱스 인코포레이티드 | 안정한 비수성 단일상 점성 비히클 및 그 비히클을이용하는 제형물 |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
AT409083B (de) | 1999-04-01 | 2002-05-27 | Sanochemia Pharmazeutika Ag | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung |
US7179483B2 (en) | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
DE10341923A1 (de) * | 2003-09-11 | 2005-04-07 | Heinl, Alexander, Dr.med. | Verwendung von Tolperison |
AT500144A1 (de) * | 2004-03-05 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
DE102005014080B4 (de) * | 2005-03-21 | 2007-11-22 | Birds Pharma Gmbh Berolina Innovative Research & Development Services | Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel |
MX2008013437A (es) * | 2006-04-20 | 2009-03-06 | Sanochemia Pharmazeutika Ag | Metodo para administrar tolperisona. |
JP5143131B2 (ja) | 2006-05-30 | 2013-02-13 | インターシア セラピューティクス,インコーポレイティド | 浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ |
PL2359808T3 (pl) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotyczne systemy dostawcze i zespoły tłokowe |
CA2683610C (en) | 2007-04-23 | 2013-01-08 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
AT505225A1 (de) | 2007-04-26 | 2008-11-15 | Sanochemia Pharmazeutika Ag | 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen |
HUP0700828A2 (en) * | 2007-12-20 | 2010-01-28 | Richter Gedeon Nyrt | Transdermal pharmaceutical compositions containing tolperisone alone and in combination |
DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
US20100249423A1 (en) * | 2009-03-09 | 2010-09-30 | Sanochemia Pharmazeutika Ag | Tolperisone controlled release tablet |
CN102438597A (zh) * | 2009-03-09 | 2012-05-02 | 丁内沙·沙蒂尔阿尔·帕特尔 | 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂 |
KR101823699B1 (ko) | 2009-09-28 | 2018-01-30 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
US20110144416A1 (en) * | 2009-12-11 | 2011-06-16 | Joshua Waddell | Infant sleeping apparatus |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
WO2012172413A1 (en) | 2011-06-16 | 2012-12-20 | Abbott Healthcare Pvt. Ltd. | Pharmaceutical composition comprising a combination of eperisone and diclofenac and process for preparing thereof |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
MX2017015504A (es) | 2015-06-03 | 2018-05-15 | Intarcia Therapeutics Inc | Sistemas de colocacion y remoción de implante. |
WO2017037812A1 (ja) * | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 酸捕捉剤を含有する貼付製剤 |
AU2017268161B2 (en) | 2016-05-16 | 2020-03-12 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
AU2018206539A1 (en) | 2017-01-03 | 2019-07-18 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58225009A (ja) * | 1982-06-23 | 1983-12-27 | Shionogi & Co Ltd | コルチコステロイド外用製剤 |
JPS6239524A (ja) * | 1985-08-13 | 1987-02-20 | Toko Yakuhin Kogyo Kk | 消炎鎮痛軟膏剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2528516A1 (de) * | 1974-07-05 | 1976-01-22 | Sandoz Ag | Neue galenische zubereitung |
HU33131A (ja) * | 1984-01-26 | 1984-10-29 | ||
US4637930A (en) * | 1984-02-08 | 1987-01-20 | Yamanouchi Pharmaceutical Co, Ltd. | Transdermal formulation of nicardipine hydrochloride |
CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
-
1988
- 1988-03-16 JP JP63062944A patent/JPH0720866B2/ja not_active Expired - Fee Related
- 1988-04-27 FI FI881978A patent/FI91361C/fi not_active IP Right Cessation
- 1988-05-03 EP EP88107085A patent/EP0295411B1/en not_active Expired - Lifetime
- 1988-05-03 DE DE8888107085T patent/DE3860550D1/de not_active Expired - Lifetime
- 1988-05-09 DK DK253988D patent/DK169016B1/da not_active IP Right Cessation
- 1988-05-09 DK DK253988A patent/DK253988A/da not_active IP Right Cessation
- 1988-05-13 CA CA000566696A patent/CA1310270C/en not_active Expired - Lifetime
- 1988-05-13 NO NO882103A patent/NO175515C/no not_active IP Right Cessation
- 1988-05-13 US US07/193,713 patent/US5059427A/en not_active Expired - Lifetime
-
1990
- 1990-08-02 US US07/561,707 patent/US5073375A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58225009A (ja) * | 1982-06-23 | 1983-12-27 | Shionogi & Co Ltd | コルチコステロイド外用製剤 |
JPS6239524A (ja) * | 1985-08-13 | 1987-02-20 | Toko Yakuhin Kogyo Kk | 消炎鎮痛軟膏剤 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06247846A (ja) * | 1993-02-22 | 1994-09-06 | Toko Yakuhin Kogyo Kk | 塩酸リトドリンの経皮吸収製剤用組成物 |
Also Published As
Publication number | Publication date |
---|---|
DK169016B1 (da) | 1994-08-01 |
NO882103D0 (no) | 1988-05-13 |
US5059427A (en) | 1991-10-22 |
EP0295411B1 (en) | 1990-09-05 |
FI91361C (fi) | 1994-06-27 |
CA1310270C (en) | 1992-11-17 |
NO175515B (no) | 1994-07-18 |
FI881978A0 (fi) | 1988-04-27 |
FI881978A (fi) | 1988-11-16 |
NO882103L (no) | 1988-11-16 |
NO175515C (no) | 1994-10-26 |
JPH0720866B2 (ja) | 1995-03-08 |
FI91361B (fi) | 1994-03-15 |
EP0295411A1 (en) | 1988-12-21 |
DK253988A (da) | 1988-11-16 |
DE3860550D1 (de) | 1990-10-11 |
DK253988D0 (da) | 1988-05-09 |
US5073375A (en) | 1991-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6452716A (en) | Endermically applicable preparation containing eperisone, tolperisone or salt thereof | |
JPS549269A (en) | Carboxylic acid esters, process for their preparation and insecticides and miticides containing the same as active constituents | |
YU174490A (sh) | Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja | |
EP0016513A3 (en) | Esters of halogenated substituted cyclopropanoic acids, their preparation and use as insecticides; fluorinated substituted benzyl alcohols, benzylchlorides and benzylbromides | |
HK1003137A1 (en) | New pyrazine derivatives their preparation and their use | |
IL66151A0 (en) | Preparation of optically pure d-or l-lactic acid by fermentation | |
IT7868238A0 (it) | Feci artificiali per l'impiego come standard di controllo per il rilevamento diagnostico di sostanze contenute nelle feci | |
JPS5214745A (en) | Preparation of phenylcarbamic acid esters | |
JPS56120623A (en) | Composition for testing caries activity of teeth | |
JPS52806A (en) | Preparation of ester | |
ES2032757T3 (es) | Inyecciones que contienen alcohol poliprenilico y el uso de estas. | |
JPS57136509A (en) | Preparation of cosmetic highly containing gamma-orizanol | |
JPS5299217A (en) | Vermin attractants | |
DE2861367D1 (en) | Esters of alpha-halogenated alcohols, method of preparation and application to the synthesis of esters of alpha-cyano substituted alcohols | |
IL56019A (en) | N,n-dialkyl-o-pyrimidinyl-carbamic acid esters,their preparation and their use as insecticides | |
JPS54145663A (en) | N*nndimethylloopyrazolyllcarbamic acid ester* its preparation and use as incecticide | |
ZA765990B (en) | 0,0-diethyl-0-(n-methoxy-2-nitrobenzimidoyl)-thiono-phosphoric acid ester process for its preparation and its use asan insecticide and acaricide | |
IL55060A0 (en) | Novel n,n-dialkyl-o-pyrimidinyl-carbamic acid esters,their preparation and their use as insecticides | |
JPS5421979A (en) | Composition for emulsifying agnet or sulubilizing agnet | |
JPS52108088A (en) | Preparation of monohydroxycarboxylic acid using microbials | |
JPS53148595A (en) | Preparation of salinomycines | |
IE40890B1 (en) | Pyrimidin(2)yl-thionophosphoric acid esters,process for their preparation and their use as insecticides,acaricides and nematocides | |
JPS53108917A (en) | Preparation of composite ester of low acid valence | |
JPS5372894A (en) | Preparation of l-serine by fermentation | |
FR2424900A2 (fr) | Esters m-phenoxybenzyliques d'acides (haloalkyloxyphenyl)-2 alcanoiques, leur preparation et leur utilisation comme insecticides et ixodicides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |